Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-23-002325
Filing Date
2023-06-29
Accepted
2023-06-29 07:10:52
Documents
7
Effectiveness Date
2023-06-29

Document Format Files

Seq Description Document Type Size
1 S-8 zk2329924.htm S-8 83571
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 6099
3 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 3863
4 EXHIBIT 107 exhibit_107.htm EX-FILING FEES 27227
5 image1.jpg GRAPHIC 173383
6 image00003.jpg GRAPHIC 12772
7 image00005.jpg GRAPHIC 21314
  Complete submission text file 0001178913-23-002325.txt   407691
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: S-8 | Act: 33 | File No.: 333-273001 | Film No.: 231054283
SIC: 2834 Pharmaceutical Preparations